Expression of somatostatin receptor in human breast carcinoma and its clinical significance

WANG Shao-hua,YU Ze-ping,LI Ning,YANG Xiao-dong,ZHANG Xin-hua,SUN Gui-qin,LI Jie-shou
DOI: https://doi.org/10.3969/j.issn.1672-2353.2006.03.003
2006-01-01
Abstract:Objective To determinate whether human primary breast invasive ductal carcinoma(HPBIDC) expresses somatostatin receptor(SSTR).Methods SSTR expression in 82 patients with invasive duct carcinoma of breast was determined by immunohistochemistry and its correlation with clinical and pathological facts was analyzed.Results IHC analyses revealed that SSTR was expressed in HPBIDC(61/82,74.4%).A significant correlation was found between SSTR expression and tumor stage(P0.001),tumor differentiation(P0.05),and there are no statistically significant relationship between the expression of SSTR,age(P0.05),and tumor size(P0.05).Conclusions SSTR expression ratio in invasive ductal carcinoma of breast is 74.4%(61/82).
What problem does this paper attempt to address?